As of Oct 26, 2026: Viatris (VTRS) has a PDUFA date for MR-107A-02 on Dec 27, 2026, in 62 days. Its Quality Score is 17. Scores as of 9:21 PM ET, 15 minutes behind.

Viatris (VTRS) logo

VTRS FDA decision on MR-107A-02

Viatris · PDUFA date

What the company said

“The FDA has assigned a PDUFA goal date of December 27, 2026.”

PDUFA date, Dec 27, 2026. As Viatris stated in its 8-K of Aug 6, 2026 (the filing).

A PDUFA date is the day the FDA has said it aims to decide on a drug. The FDA can decide earlier, or extend its review, often by three months.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert before VTRS's FDA date

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How VTRS's stock moved on its past FDA days, for Pro members. Pro members also see whether its cash lasts past Dec 27, and the members' FDA calendar with filters and optional alerts.

More on VTRS and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.

The company set the date; the FDA can act before it or extend it. The score is delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.